These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

406 related articles for article (PubMed ID: 15784128)

  • 21. Partial D, weak D types, and novel RHD alleles among 33,864 multiethnic patients: implications for anti-D alloimmunization and prevention.
    Denomme GA; Wagner FF; Fernandes BJ; Li W; Flegel WA
    Transfusion; 2005 Oct; 45(10):1554-60. PubMed ID: 16181204
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Calculation of feto-maternal haemorrhage volume using various morphological parameters and various formulas].
    Gielezynska A; Fabijańska-Mitek J; Debska M
    Pol Merkur Lekarski; 2011 Mar; 30(177):228-30. PubMed ID: 21545004
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Detection of fetomaternal hemorrhage.
    Kim YA; Makar RS
    Am J Hematol; 2012 Apr; 87(4):417-23. PubMed ID: 22231030
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quantification of foetomaternal haemorrhage. An analysis of two cytometric techniques and a semiquantitative gel agglutination test.
    Gómez-Arbonés X; Pinacho A; Ortiz P; Maciá J; Gallart M; Araguás C; Sánchez JM; Teixidó M
    Clin Lab Haematol; 2002 Feb; 24(1):47-53. PubMed ID: 11843899
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Monoclonal reagents for rhesus-D typing of Irish patients and donors: a review.
    Williams M
    Br J Biomed Sci; 2000; 57(2):142-9. PubMed ID: 10912289
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Detection of weak D and D(VI) red cells in D-negative mixtures by flow cytometry: implications for feto-maternal haemorrhage quantification and D typing policies for newborns.
    Lloyd-Evans P; Guest AR; Voak D; Scott ML
    Br J Haematol; 1999 Mar; 104(3):621-5. PubMed ID: 10086805
    [TBL] [Abstract][Full Text] [Related]  

  • 27. RhD haemolytic disease of the fetus and the newborn.
    Urbaniak SJ; Greiss MA
    Blood Rev; 2000 Mar; 14(1):44-61. PubMed ID: 10805260
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Practical and theoretical considerations in blood group serology of red cells (author's transl)].
    Speiser P; Pausch V; Weirather M
    Wien Klin Wochenschr; 1980; 92(11):379-85. PubMed ID: 6775417
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Feto - maternal haemorrhage in parturients: Incidence and its determinants.
    Adeniji AO; Mabayoje VO; Raji AA; Muhibi MA; Tijani AA; Adeyemi AS
    J Obstet Gynaecol; 2008 Jan; 28(1):60-3. PubMed ID: 18259901
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quantification of feto-maternal hemorrhage: selection of techniques for a resource-poor setting.
    Agarwal P; Sekhar Das S; Gupta R; Khetan D; Chaudhary R
    Gynecol Obstet Invest; 2011; 71(1):47-52. PubMed ID: 21160194
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A combined flow cytometry-based method for fetomaternal hemorrhage and maternal D.
    Radel DJ; Penz CS; Dietz AB; Gastineau DA
    Transfusion; 2008 Sep; 48(9):1886-91. PubMed ID: 18513253
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Flow Cytometry in Detection of Fetal Red Blood Cells and Maternal F Cells to Identify Fetomaternal Hemorrhage.
    Farias MG; Dal Bó S; Castro SM; da Silva AR; Bonazzoni J; Scotti L; Costa SH
    Fetal Pediatr Pathol; 2016; 35(6):385-391. PubMed ID: 27494244
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Massive fetomaternal hemorrhage: clearance of fetal red blood cells after intravenous anti-D prophylaxis monitored by flow cytometry.
    Larsen R; Berkowicz A; Lousen T; Hedegaard M; Clausen FB; Krog GR; Dziegiel MH
    Transfusion; 2008 Aug; 48(8):1707-12. PubMed ID: 18482192
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Novel weak D types 31 and 32: adsorption-elution-supported D antigen analysis and comparison to prevalent weak D types.
    Körmöczi GF; Förstemann E; Gabriel C; Mayr WR; Schönitzer D; Gassner C
    Transfusion; 2005 Oct; 45(10):1574-80. PubMed ID: 16181207
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Possibility to identify fetomaternal haemorrhage].
    Studnicková M; L'ubuský M; Ordeltová M; Procházka M
    Ceska Gynekol; 2010 Oct; 75(5):443-6. PubMed ID: 21374922
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Massive antenatal fetomaternal hemorrhage: evidence for long-term survival of fetal red blood cells.
    Dziegiel MH; Koldkjaer O; Berkowicz A
    Transfusion; 2005 Apr; 45(4):539-44. PubMed ID: 15819674
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Monitoring the clearance of fetal RhD-positive red cells in FMH following RhD immunoglobulin administration.
    Lubenko A; Williams M; Johnson A; Pluck J; Armstrong D; MacLennan S
    Transfus Med; 1999 Dec; 9(4):331-5. PubMed ID: 10583887
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Flow cytometric assessment of feto-maternal hemorrhage; a comparison with Betke-Kleihauer.
    Fernandes BJ; von Dadelszen P; Fazal I; Bansil N; Ryan G
    Prenat Diagn; 2007 Jul; 27(7):641-3. PubMed ID: 17441223
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Many genetically defined ABO subgroups exhibit characteristic flow cytometric patterns.
    Hult AK; Olsson ML
    Transfusion; 2010 Feb; 50(2):308-23. PubMed ID: 19804572
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The application of flow cytometry in analysis of erythrocyte antigen determinants].
    Amemiya Y; Hashimoto Y; Obata T; Nakagi Y; Miura Y
    Rinsho Ketsueki; 1990 Jun; 31(6):702-12. PubMed ID: 1699003
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.